elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38430335-FB1B7235-4CFD-4759-B6D2-4EC2DE3BBEE2
Q38430335-FB1B7235-4CFD-4759-B6D2-4EC2DE3BBEE2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38430335-FB1B7235-4CFD-4759-B6D2-4EC2DE3BBEE2
A phase I study of cabozantinib (XL184) in patients with renal cell cancer.
P2093
Q38430335-FB1B7235-4CFD-4759-B6D2-4EC2DE3BBEE2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38430335-FB1B7235-4CFD-4759-B6D2-4EC2DE3BBEE2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d19fb8574cab2f7c9c8c5c378308e8daabbe513d
P1545
4
http://www.w3.org/2001/XMLSchema#string
P2093
S Morrissey
http://www.w3.org/2001/XMLSchema#string